Literature DB >> 15281435

Sleep disturbances associated with periodic leg movements in chronic sarcoidosis.

Johan Verbraecken1, Elske Hoitsma, Chris P M van der Grinten, Nicolle A M Cobben, Emiel F M Wouters, Marjolein Drent.   

Abstract

BACKGROUND AND AIM OF THE WORK: Many sarcoidosis patients suffer from fatigue and sleep disturbances. Recently, it was demonstrated that obstructive sleep apnea (OSA) is rather common in sarcoidosis. Moreover, sheet intolerance and painful legs are frequently reported in sarcoidosis patients. These symptoms might interfere with sleep quality.
METHODS: In order to determine the relationship between objective and subjective sleep disturbance full polysomnography, including leg EMG analysis, was performed in 46 chronic sarcoidosis patients indicating awakening unrefreshed in the morning.
RESULTS: In 20 (44%) patients OSA activity [60% with PLM (n=12), 40% without (n = 8)] was demonstrated, while in 7 patients (15%) significant PLM without OSA were found. In 19 patients (42%) no OSA or PLM activity was present. Moreover restless legs (RLS) were reported by 52% of the patients (45% in OSA; 71% in PLM; 47% in others). Distribution of sleep stages and sleep fragmentation was comparable in all groups. In a healthy snoring control group (n = 102) a prevalence of PLM was found in 13.7% (17.8% in men; 3.4% in women), while RLS were only reported by 1.4% (men) and 6.9% (women).
CONCLUSIONS: Sleep disturbance (OSA and/or PLM) and RLS were demonstrated in more than half of the studied sarcoidosis patients. A high prevalence of RLS or PLM (primary and secondary) has not been reported before in sarcoidosis. Further studies are needed to establish whether RLS, OSA and/or PLM might contribute to fatigue and whether fatigue complaints improve after treatment of RLS/PLM/OSA.

Entities:  

Mesh:

Year:  2004        PMID: 15281435     DOI: 10.1007/s11083-004-3716-2

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  5 in total

1.  Incidence of restless legs syndrome and its correlates.

Authors:  Pooja Budhiraja; Rohit Budhiraja; James L Goodwin; Richard P Allen; Anne B Newman; Brian B Koo; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

2.  Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.

Authors:  Elyse E Lower; Atul Malhotra; Victoria Surdulescu; Robert P Baughman
Journal:  J Pain Symptom Manage       Date:  2012-08-20       Impact factor: 3.612

3.  Obstructive sleep apnea is common in patients with interstitial lung disease.

Authors:  Aylin Pihtili; Zuleyha Bingol; Esen Kiyan; Caglar Cuhadaroglu; Halim Issever; Ziya Gulbaran
Journal:  Sleep Breath       Date:  2013-04-08       Impact factor: 2.816

Review 4.  Drug-induced comorbidities in patients with sarcoidosis.

Authors:  Marjolein Drent; Naomi T Jessurun; Petal A Wijnen; Otto Bekers; Aalt Bast
Journal:  Curr Opin Pulm Med       Date:  2022-07-18       Impact factor: 2.868

Review 5.  Managing fatigue in sarcoidosis - A systematic review of the evidence.

Authors:  Chris Atkins; Andrew M Wilson
Journal:  Chron Respir Dis       Date:  2016-08-09       Impact factor: 2.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.